亚辉龙蹭热点，被证监会立案！

Core Viewpoint - The China Securities Regulatory Commission (CSRC) has initiated an investigation into Shenzhen Yahui Long Biotechnology Co., Ltd. (referred to as "Yahui Long") for suspected misleading statements related to a strategic cooperation framework agreement disclosed on January 7 [1] Group 1: Investigation and Regulatory Actions - On February 6, Yahui Long received a notice from the CSRC regarding the investigation for violations of information disclosure laws [1] - The company stated that all its business activities are operating normally and it will cooperate with the CSRC during the investigation [1] - The CSRC aims to maintain healthy market development through this investigation [1] Group 2: Strategic Cooperation and Market Response - Yahui Long announced a strategic cooperation framework agreement with Shenzhen Brain Machine Starlink Technology Co., Ltd. (referred to as "Brain Machine Starlink") to develop brain-machine interface products [3] - Following the announcement, the Shanghai Stock Exchange (SSE) issued an inquiry letter requesting additional information about the cooperation, including technical routes and product statuses [4] - In response to the SSE's inquiry, Yahui Long clarified that Brain Machine Starlink is a small company with limited commercialization capabilities and that the products are still in early development stages [5] Group 3: Market Performance - On January 6, the stock price of Yahui Long increased by 6.52%, with trading volume rising by 299% compared to the previous trading day [6]